Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population

Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population

ABSTRACT Background Sarcopenia is defined as the loss of muscle mass, strength, and/or performance. It is strongly associated with all‐cause mortality. Fibroblast growth factor 23 (FGF23) is markedly elevated in patients with chronic kidney disease, especially those receiving maintenance dialysis. F...

Full description

Saved in:
Bibliographic Details
Main Authors: Limy Wong, Rachel Kenny, Jenny Y. Y. Ooi, Yung Shing Tsang, Emily Schembri, Lawrence P. McMahon
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
dialysis
FGF23
muscle strength
sarcopenia
Online Access:https://doi.org/10.1002/jcsm.13848
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items